NEW YORK (GenomeWeb News) – Whatman will distribute GenVault’s GenSolve DNA recovery kits in North America under a non-exclusive pact announced today.
The kit enables users of Whatman’s FTA 1 card to recover high-quality DNA from archived samples, said Florham Park, NJ-based GenVault. The firm said the recovered DNA is double-stranded and is compatible with downstream genetic assays, such as genotyping and PCR.
Richard Dool, senior vice president of North America for Whatman, said the alliance would allow Whatman’s FTA customers “to extend the number of tests they can run with their archived samples.”
Whatman was acquired last month by GE Healthcare for £363 million ($713 million).